T. cruzi
Chagas disease
T. cruzi and T. brucei have little in common
transmission of T. cruzi
Triatomine insects
T or F. T. c. enters a variety of host cells and multiplies in cytoplasm
T
T or F. Triatomine bugs are active in the day
F! Active at night
- typically live in the wall or roof cracks of poorly constructed homes in rural areas
what is an amastigote?
protest cell that does not have visible external flagella or cilia
intracellular phase in life-cycle of trypanosomes that replicates
T.c. has this stage
T. cruzi is characterized by two phases…
acute and chronic
- acute = 8 to 12 weeks after transmission
- chronic = host immune response decreases parasite replication so parasitemia falls below levels detectable by microscopy, acute symptoms resolve
what happens if no successful therapy
8-12 acute symptoms and chronic phase lasts for life
inflammation lesion caused by T. c. at site of entry is called
chagoma
- if periocular tissue and painless edema = Romana sign
Romana sign
T. c. enters periocular site and painless edema appear
disease presentation of Chagas
fever, chills, anorexia, malaise, edema of face and lower extremities, lymphadenopathy and hepatosplenomegaly
** sometimes CNS involvement and acute myocarditis w arrhythmias
~ ___ to ___% will develop cardiac and/or GI forms of T.c. disease
20 to 30%
diagnosis of T. c.
congenital Chagas
microscopic examination of cord blood or PCR or serology is not indicated as maternal Abs will be present in newborn
if microscopy and/or PCR negative = serology (IgG should be done 6-9 mos later)
why do we have to do 2 serologic assays to diagnose T. c.
to rule out FP with
- malaria
- Leishmania
- syphilis
- some other parasitic and non-parasitic infections
two first-line serological tetss for T.c.
EIA (enzyme immunoassay) on recombinant T. c. antigens and immunoblot (ESA)
T or F. There is no clinical evidence that antitryp therapy can reverse established Chagas cardiac disease
T! so prevention is key to avoid chronic Chagas cardiomyopathy (CCC)
what is the focus for treatment on patients w advanced heart disease
supportive care for heart failure, arrhythmia, and thromboembolism
T or F. Antitrypanosomal therapy has not been proven to affect progression of GI disease
T! management focuses on symptom amelioration
T or F. Risk of Chagas disease to travelers is low
T!